Pfizer investor relations contact

Pfizer’s transfer agent, Computershare Trust Company, N.A. ("Computershare") administers our direct stock purchase and dividend reinvestment plan for Pfizer common stock. To learn more, please contact Computershare at: +1-800-PFE-9393 (+1-800-733-9393) (U.S. and Canada) +1-781-575-4591. (Outside U.S. and Canada) Contact Pfizer Media Relations. This information is intended for media professionals only. To ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may ONLY respond to calls and emails from professional journalists. If you are not a journalist, please visit the Contact Us Page to reach

29 Jul 2019 Contacts. Mylan. Media Relations: Investor Relations: Christine Waller Mylan and Pfizer will host Investor Conference Call, Monday, July 29,  11 Jun 2018 In addition to Investor Relations, Pfizer's Operations Planning and Analysis department reports to Mr. Triano. He is also a member of Pfizer's  16 Dec 2019 Pfizer also announced plans to host an Investor Day on Tuesday, March 31, that address some of the world's greatest unmet needs in healthcare. on the Pfizer's Investor Relations website (www.pfizer.com/investors) at the  Pfizer Announces Positive Preliminary Results from a Proof-of-Concept Phase 2 Study (B7471003) of its 20-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasive Disease and Otitis Media in Healthy Infants. Pfizer’s transfer agent, Computershare Trust Company, N.A. ("Computershare") administers our direct stock purchase and dividend reinvestment plan for Pfizer common stock. To learn more, please contact Computershare at: +1-800-PFE-9393 (+1-800-733-9393) (U.S. and Canada) +1-781-575-4591. (Outside U.S. and Canada) Contact Pfizer Media Relations. This information is intended for media professionals only. To ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may ONLY respond to calls and emails from professional journalists. If you are not a journalist, please visit the Contact Us Page to reach Pfizer Investor Relations: Information for the "Educated" Investor There are "ups" and "downs" in practically every business and stock. Although there are no guarantees about the stock market or Pfizer stock, before you invest in any security, you can help protect yourself by being an educated investor .

Pfizer Announces Positive Preliminary Results from a Proof-of-Concept Phase 2 Study (B7471003) of its 20-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasive Disease and Otitis Media in Healthy Infants.

Why Invest - Our Story. Pfizer Inc. is a research-based, global biopharmaceutical company. We apply science and our global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development and manufacture of healthcare products. Our global portfolio includes medicines and vaccines, Pfizer is a leader in corporate governance, and good corporate governance is fundamental to Pfizer's business. A cornerstone of governance at Pfizer is our shareholder outreach program, through which we regularly engage with our investors and stakeholders around the world to gain insight into the burgeoning issues at the forefront of their business policies and guidelines. SSN Protection Policy. In the ordinary course of business, Pfizer Inc sometimes collects Social Security numbers to fulfill legal or regulatory obligations or for other administrative purposes. It is the policy of Pfizer Inc to avoid the unnecessary collection of Social Security numbers; to limit access to Social Security numbers that we collect; Forward-Looking Statements of Pfizer Inc. This webcast may contain forward-looking statements about, among other things, our anticipated future operating and financial performance, business plans and prospects, in-line products and product candidates, strategic reviews, capital allocation, business-development plans, the benefits expected from the reorganization of our commercial operations Pfizer Outlines Five-Point Plan to Battle COVID-19 Pfizer today issued a five-point plan calling on the biopharmaceutical industry to join the company in committing to unprecedented collaboration to combat COVID-19. The Flying Tesla (TSLA) Is Here: What Investors Can Learn From Its Amazing Surge 2 days ago 3 Growth Stocks to Buy and Hold for the Next 50 Years Jan 19, 2020

To report an adverse drug reaction (or suspected side effect) experienced with a Pfizer medication (prescription or a vaccine), please contact us at 1 866 723-7111 or by fax at 1 855 242-5652. Reports can be made directly to Health Canada as well through the Canada Vigilance Program at 1 866 234-2345.

Computershare Investor Services P.O. Box 505000. Louisville, KY 40233-5000. Be Sure to Include: Name; Address; Daytime phone number. account number (if  Can I buy or sell stock directly through Pfizer? How can I determine the cost- basis for my Pfizer stock? How can I change the address on my account? To ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may ONLY respond to calls and emails from professional  17 Jun 2019 Pfizer Inc. Investor Relations: Media Relations: Chuck Triano. +1 (212) 733-3901. Charles. Investor Relations · Contact · Careers · Advertise · Nasdaq MarketSIte · Trust Center · Privacy · Cookies · Legal 

Most Recent Presentation. Thumbnails Document Pfizer Postpones Investor Day Scheduled for March 31, 2020 Due to Coronavirus Concerns. 03/18/2020.

Pfizer Investor Events. Healthcare Pfizer Investor Day · Webcast Pfizer Quarterly Corporate Performance - First Quarter 2020 Most Recent Presentation. Showing 1-9 of 9. Computershare Investor Services P.O. Box 505000. Louisville, KY 40233-5000. Be Sure to Include: Name; Address; Daytime phone number. account number (if 

These documents (when they are available) can also be obtained free of charge from Mylan, upon written request to Mylan, at (724) 514-1813 or [email protected] mylan.com or from Pfizer on Pfizer’s internet website at https://investors.Pfizer.com/financials/sec-filings/default.aspx or by contacting Pfizer’s Investor Relations Department at (212) 733-2323, as applicable.

Pfizer is a leader in corporate governance, and good corporate governance is fundamental to Pfizer's business. A cornerstone of governance at Pfizer is our shareholder outreach program, through which we regularly engage with our investors and stakeholders around the world to gain insight into the burgeoning issues at the forefront of their business policies and guidelines. SSN Protection Policy. In the ordinary course of business, Pfizer Inc sometimes collects Social Security numbers to fulfill legal or regulatory obligations or for other administrative purposes. It is the policy of Pfizer Inc to avoid the unnecessary collection of Social Security numbers; to limit access to Social Security numbers that we collect; Forward-Looking Statements of Pfizer Inc. This webcast may contain forward-looking statements about, among other things, our anticipated future operating and financial performance, business plans and prospects, in-line products and product candidates, strategic reviews, capital allocation, business-development plans, the benefits expected from the reorganization of our commercial operations Pfizer Outlines Five-Point Plan to Battle COVID-19 Pfizer today issued a five-point plan calling on the biopharmaceutical industry to join the company in committing to unprecedented collaboration to combat COVID-19. The Flying Tesla (TSLA) Is Here: What Investors Can Learn From Its Amazing Surge 2 days ago 3 Growth Stocks to Buy and Hold for the Next 50 Years Jan 19, 2020 Pfizer Declares First-Quarter 2020 Dividend and Announces Upcoming Investor Day to Highlight Strength of Innovative R&D Pipeline Board of Directors approves first-quarter 2020 cash dividend of $0.38 per share Investor Day scheduled for March 31, 2020 to showcase mid-to-late-stage R&D pipeline progress and commercial momentum across Biopharma businesses These documents (when they are available) can also be obtained free of charge from Mylan, upon written request to Mylan, at (724) 514-1813 or [email protected] mylan.com or from Pfizer on Pfizer’s internet website at https://investors.Pfizer.com/financials/sec-filings/default.aspx or by contacting Pfizer’s Investor Relations Department at (212) 733-2323, as applicable.

To ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may ONLY respond to calls and emails from professional  17 Jun 2019 Pfizer Inc. Investor Relations: Media Relations: Chuck Triano. +1 (212) 733-3901. Charles. Investor Relations · Contact · Careers · Advertise · Nasdaq MarketSIte · Trust Center · Privacy · Cookies · Legal